GLI1 and breast carcinoma: Our previous studies showed that GLI signaling is activated downstream of EMT transcription factors in both SMO-dependent and SMO-independent manners (Neelakantan et al., 2017), providing a potential explanation for why SMO inhibitors are not efficacious in breast cancers with evidence of activated Hh signaling.